Please enable JavaScript to continue using this application.

Compare $BOLD vs $CNTB | Chartloom

Compare

$BOLD vs $CNTB

Boundless Bio Inc · Connect Biopharma Holdings Ltd

BOLD

Boundless Bio Inc

CNTB

Connect Biopharma Holdings Ltd

Compare $BOLD vs $CNTB

Comparing Boundless Bio Inc and Connect Biopharma Holdings Ltd

BOLDBoundless Bio Inc

CNTBConnect Biopharma Holdings Ltd

BOLDBoundless Bio Inc

Market cap

$57M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

107.4%

52W performance

94.6%

FCF yield

-99.8%

CNTBConnect Biopharma Holdings Ltd

Market cap

$48M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.55x

Rev growth (TTM)

—

YTD performance

-65.5%

52W performance

-52.2%

FCF yield

-125.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BOLD

CNTB

Detailed metrics comparison

BOLD

Boundless Bio Inc

CNTB

Connect Biopharma Holdings Ltd

Market Cap

BOLD$57M

CNTB$48M

Enterprise Value

BOLD$37M

CNTB$21M

Price

BOLD$2.53

CNTB$0.87

P/E Ratio

BOLDN/A

CNTBN/A

P/S Ratio

BOLD0.00x

CNTB16.42x

EV/Sales

BOLD0.00x

CNTB7.27x

EV/EBITDA

BOLD0.00x

CNTB0.00x

P/B Ratio

BOLD0.90x

CNTB2.17x

P/FCF Ratio

BOLDN/A

CNTBN/A

EV/FCF

BOLD-0.65x

CNTB-0.35x

PEG Ratio

BOLDN/A

CNTBN/A

Forward P/E (NTM)

BOLDN/A

CNTBN/A

Forward P/S (NTM)

BOLDN/A

CNTB5.55x

Revenue (TTM)

BOLD$0

CNTB$3M

Revenue Growth (YoY)

BOLDN/A

CNTBN/A

Forward Rev Growth

BOLD0.0%

CNTB98.8%

Gross Margin (TTM)

BOLD0.0%

CNTB0.0%

Operating Margin (TTM)

BOLD0.0%

CNTB0.0%

EBITDA Margin (TTM)

BOLD0.0%

CNTB-2361.3%

Net Margin (TTM)

BOLD0.0%

CNTB-2336.3%

FCF Margin (TTM)

BOLDN/A

CNTB-2053.3%

Net Income (TTM)

BOLD$-64M

CNTB$-69M

FCF (TTM)

BOLD$-57M

CNTB$-61M

EPS (TTM)

BOLD-$2.85

CNTB-$1.24

ROE (TTM)

BOLD-7089.0%

CNTB-16541.0%

ROA (TTM)

BOLD-4737.0%

CNTB-12158.0%

ROIC (TTM)

BOLD-7089.0%

CNTB-16541.0%

Cash

BOLD$20M

CNTB$27M

Debt

BOLD$0

CNTB$0

Net Cash/Debt

BOLD$20M

CNTB$27M

Current Ratio (TTM)

BOLD9.48x

CNTB2.37x

Quick Ratio (TTM)

BOLD9.35x

CNTB2.11x

Debt/Equity (TTM)

BOLD0.00x

CNTB0.00x

Debt/Assets (TTM)

BOLD0.0%

CNTB0.0%

Interest Coverage (TTM)

BOLDN/A

CNTBN/A

Net Debt/EBITDA (TTM)

BOLD0.00x

CNTB0.00x

Beta

BOLD0.44

CNTB-0.07

52W Performance

BOLD94.6%

CNTB-52.2%

YTD Performance

BOLD107.4%

CNTB-65.5%

% from 52W High

BOLD-20.0%

CNTB-77.2%

% from 52W Low

BOLD163.2%

CNTB2.3%

Asset Turnover (TTM)

BOLD0.00x

CNTB0.05x

FCF Yield (TTM)

BOLD-99.8%

CNTB-125.1%

Earnings Yield (TTM)

BOLD-112.6%

CNTB-142.3%

Dividend Yield (TTM)

BOLDN/A

CNTBN/A

Rule of 40

BOLD0.0

CNTB-2,053.3

EV/GP/RG

BOLDN/A

CNTBN/A

Ticker research

View BOLD research View CNTB research

Metric	BOLD Boundless Bio Inc	CNTB Connect Biopharma Holdings Ltd
Market & Valuation
Market Cap	$57M	$48M
Enterprise Value	$37M	$21M
Price	$2.53	$0.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	16.42x
EV/Sales	0.00x	7.27x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.90x	2.17x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.65x	-0.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.55x
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	98.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2361.3%
Net Margin (TTM)	0.0%	-2336.3%
FCF Margin (TTM)	N/A	-2053.3%
Net Income (TTM)	$-64M	$-69M
FCF (TTM)	$-57M	$-61M
EPS (TTM)	-$2.85	-$1.24
ROE (TTM)	-7089.0%	-16541.0%
ROA (TTM)	-4737.0%	-12158.0%
ROIC (TTM)	-7089.0%	-16541.0%
Financial Health
Cash	$20M	$27M
Debt	$0	$0
Net Cash/Debt	$20M	$27M
Current Ratio (TTM)	9.48x	2.37x
Quick Ratio (TTM)	9.35x	2.11x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.44	-0.07
52W Performance	94.6%	-52.2%
YTD Performance	107.4%	-65.5%
% from 52W High	-20.0%	-77.2%
% from 52W Low	163.2%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-99.8%	-125.1%
Earnings Yield (TTM)	-112.6%	-142.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,053.3
EV/GP/RG	N/A	N/A
Ticker research	View BOLD research	View CNTB research

Valuation

P/S Ratio

BOLD

0.00x

CNTB

16.42x

EV/FCF

BOLD

-0.65x

CNTB

-0.35x

Growth & revenue

Forward Revenue Growth

CNTB

98.8%

BOLD

0.0%

Profitability & performance

Gross Margin

BOLD

0.0%

CNTB

0.0%

ROE

BOLD

-7089.0%

CNTB

-16541.0%

FCF Yield %

BOLD

-99.8%

CNTB

-125.1%

52-Week Performance

BOLD

94.6%

CNTB

-52.2%

Detailed metrics comparison

BOLD

Boundless Bio Inc

CNTB

Connect Biopharma Holdings Ltd

Market Cap

BOLD$57M

CNTB$48M

Enterprise Value

BOLD$37M

CNTB$21M

Price

BOLD$2.53

CNTB$0.87

P/E Ratio

BOLDN/A

CNTBN/A

P/S Ratio

BOLD0.00x

CNTB16.42x

EV/Sales

BOLD0.00x

CNTB7.27x

EV/EBITDA

BOLD0.00x

CNTB0.00x

P/B Ratio

BOLD0.90x

CNTB2.17x

P/FCF Ratio

BOLDN/A

CNTBN/A

EV/FCF

BOLD-0.65x

CNTB-0.35x

PEG Ratio

BOLDN/A

CNTBN/A

Forward P/E (NTM)

BOLDN/A

CNTBN/A

Forward P/S (NTM)

BOLDN/A

CNTB5.55x

Revenue (TTM)

BOLD$0

CNTB$3M

Revenue Growth (YoY)

BOLDN/A

CNTBN/A

Forward Rev Growth

BOLD0.0%

CNTB98.8%

Gross Margin (TTM)

BOLD0.0%

CNTB0.0%

Operating Margin (TTM)

BOLD0.0%

CNTB0.0%

EBITDA Margin (TTM)

BOLD0.0%

CNTB-2361.3%

Net Margin (TTM)

BOLD0.0%

CNTB-2336.3%

FCF Margin (TTM)

BOLDN/A

CNTB-2053.3%

Net Income (TTM)

BOLD$-64M

CNTB$-69M

FCF (TTM)

BOLD$-57M

CNTB$-61M

EPS (TTM)

BOLD-$2.85

CNTB-$1.24

ROE (TTM)

BOLD-7089.0%

CNTB-16541.0%

ROA (TTM)

BOLD-4737.0%

CNTB-12158.0%

ROIC (TTM)

BOLD-7089.0%

CNTB-16541.0%

Cash

BOLD$20M

CNTB$27M

Debt

BOLD$0

CNTB$0

Net Cash/Debt

BOLD$20M

CNTB$27M

Current Ratio (TTM)

BOLD9.48x

CNTB2.37x

Quick Ratio (TTM)

BOLD9.35x

CNTB2.11x

Debt/Equity (TTM)

BOLD0.00x

CNTB0.00x

Debt/Assets (TTM)

BOLD0.0%

CNTB0.0%

Interest Coverage (TTM)

BOLDN/A

CNTBN/A

Net Debt/EBITDA (TTM)

BOLD0.00x

CNTB0.00x

Beta

BOLD0.44

CNTB-0.07

52W Performance

BOLD94.6%

CNTB-52.2%

YTD Performance

BOLD107.4%

CNTB-65.5%

% from 52W High

BOLD-20.0%

CNTB-77.2%

% from 52W Low

BOLD163.2%

CNTB2.3%

Asset Turnover (TTM)

BOLD0.00x

CNTB0.05x

FCF Yield (TTM)

BOLD-99.8%

CNTB-125.1%

Earnings Yield (TTM)

BOLD-112.6%

CNTB-142.3%

Dividend Yield (TTM)

BOLDN/A

CNTBN/A

Rule of 40

BOLD0.0

CNTB-2,053.3

EV/GP/RG

BOLDN/A

CNTBN/A

Ticker research

View BOLD research View CNTB research

Metric	BOLD Boundless Bio Inc	CNTB Connect Biopharma Holdings Ltd
Market & Valuation
Market Cap	$57M	$48M
Enterprise Value	$37M	$21M
Price	$2.53	$0.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	16.42x
EV/Sales	0.00x	7.27x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.90x	2.17x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.65x	-0.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.55x
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	98.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2361.3%
Net Margin (TTM)	0.0%	-2336.3%
FCF Margin (TTM)	N/A	-2053.3%
Net Income (TTM)	$-64M	$-69M
FCF (TTM)	$-57M	$-61M
EPS (TTM)	-$2.85	-$1.24
ROE (TTM)	-7089.0%	-16541.0%
ROA (TTM)	-4737.0%	-12158.0%
ROIC (TTM)	-7089.0%	-16541.0%
Financial Health
Cash	$20M	$27M
Debt	$0	$0
Net Cash/Debt	$20M	$27M
Current Ratio (TTM)	9.48x	2.37x
Quick Ratio (TTM)	9.35x	2.11x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.44	-0.07
52W Performance	94.6%	-52.2%
YTD Performance	107.4%	-65.5%
% from 52W High	-20.0%	-77.2%
% from 52W Low	163.2%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-99.8%	-125.1%
Earnings Yield (TTM)	-112.6%	-142.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,053.3
EV/GP/RG	N/A	N/A
Ticker research	View BOLD research	View CNTB research